List of Tables
Table 1. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibody Drug Conjugate (ADC)
Table 3. Key Players of Bispecific Antibody (BsAb)
Table 4. Global Next Generation Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Next Generation Antibody Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Next Generation Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Next Generation Antibody Therapeutics Market Share by Region (2020-2025)
Table 8. Global Next Generation Antibody Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Next Generation Antibody Therapeutics Market Share by Region (2026-2031)
Table 10. Next Generation Antibody Therapeutics Market Trends
Table 11. Next Generation Antibody Therapeutics Market Drivers
Table 12. Next Generation Antibody Therapeutics Market Challenges
Table 13. Next Generation Antibody Therapeutics Market Restraints
Table 14. Global Next Generation Antibody Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Next Generation Antibody Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2024)
Table 17. Ranking of Global Top Next Generation Antibody Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Next Generation Antibody Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Next Generation Antibody Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Next Generation Antibody Therapeutics, Product and Application
Table 21. Global Key Players of Next Generation Antibody Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Next Generation Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Next Generation Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Next Generation Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Next Generation Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Next Generation Antibody Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Next Generation Antibody Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Next Generation Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Next Generation Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche Next Generation Antibody Therapeutics Product
Table 49. Roche Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Amgen Company Details
Table 52. Amgen Business Overview
Table 53. Amgen Next Generation Antibody Therapeutics Product
Table 54. Amgen Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer Next Generation Antibody Therapeutics Product
Table 59. Pfizer Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Next Generation Antibody Therapeutics Product
Table 64. Takeda Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Daiichi Sankyo Company Details
Table 67. Daiichi Sankyo Business Overview
Table 68. Daiichi Sankyo Next Generation Antibody Therapeutics Product
Table 69. Daiichi Sankyo Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Daiichi Sankyo Recent Development
Table 71. Seagen Company Details
Table 72. Seagen Business Overview
Table 73. Seagen Next Generation Antibody Therapeutics Product
Table 74. Seagen Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Seagen Recent Development
Table 76. Astellas Company Details
Table 77. Astellas Business Overview
Table 78. Astellas Next Generation Antibody Therapeutics Product
Table 79. Astellas Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Astellas Recent Development
Table 81. Immunomedics Company Details
Table 82. Immunomedics Business Overview
Table 83. Immunomedics Next Generation Antibody Therapeutics Product
Table 84. Immunomedics Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Immunomedics Recent Development
Table 86. GSK Company Details
Table 87. GSK Business Overview
Table 88. GSK Next Generation Antibody Therapeutics Product
Table 89. GSK Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 90. GSK Recent Development
Table 91. Immunocore Company Details
Table 92. Immunocore Business Overview
Table 93. Immunocore Next Generation Antibody Therapeutics Product
Table 94. Immunocore Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Immunocore Recent Development
Table 96. ADC Therapeutics Company Details
Table 97. ADC Therapeutics Business Overview
Table 98. ADC Therapeutics Next Generation Antibody Therapeutics Product
Table 99. ADC Therapeutics Revenue in Next Generation Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 100. ADC Therapeutics Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Next Generation Antibody Therapeutics Picture
Figure 2. Global Next Generation Antibody Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Next Generation Antibody Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Antibody Drug Conjugate (ADC) Features
Figure 5. Bispecific Antibody (BsAb) Features
Figure 6. Global Next Generation Antibody Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Next Generation Antibody Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Haemophilia Case Studies
Figure 10. Other Non-Cancer Diseases Case Studies
Figure 11. Next Generation Antibody Therapeutics Report Years Considered
Figure 12. Global Next Generation Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Next Generation Antibody Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Next Generation Antibody Therapeutics Market Share by Region: 2024 VS 2031
Figure 15. Global Next Generation Antibody Therapeutics Market Share by Players in 2024
Figure 16. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Next Generation Antibody Therapeutics Revenue in 2024
Figure 18. North America Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Next Generation Antibody Therapeutics Market Share by Country (2020-2031)
Figure 20. United States Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Next Generation Antibody Therapeutics Market Share by Country (2020-2031)
Figure 24. Germany Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Next Generation Antibody Therapeutics Market Share by Region (2020-2031)
Figure 32. China Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Next Generation Antibody Therapeutics Market Share by Country (2020-2031)
Figure 40. Mexico Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Next Generation Antibody Therapeutics Market Share by Country (2020-2031)
Figure 44. Turkey Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Next Generation Antibody Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 48. Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 50. Takeda Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 51. Daiichi Sankyo Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 52. Seagen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 53. Astellas Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 54. Immunomedics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 55. GSK Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 56. Immunocore Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 57. ADC Therapeutics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed